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Résumé 
Objectifs : La thérapie photodynamique a pour but la destruction sélective du tissu 
néoplasique par interaction de lumière, d'oxygène et d'une substance 
photosensibilisatrice (la Protoporphyrine IX dans notre étude). Malgré une 
accumulation sélective du photosensibilisateur dans le tissu tumoral,, la thérapie 
photodynamique du carcinome urothélial de la vessie peut endommager les cellules 
normales de l'épithélium urinaire. La prévention de ces lésions est importante pour la 
régénération de la muqueuse. Notre étude sur un modèle in vitro d'urothélium porcin 
étudie l'influence de la concentration du photosensibilisateur, des paramètres 
d'irradiation et de la production d'intermédiaires réactifs de l'oxygène (ROS) sur les 
effets photodynamique. Le but était de déterminer les conditions seuil pour épargner 
l'urothélium sain. 
Méthode: Dans une chambre de culture transparente à deux compartiments, des 
muqueuses vésicales de porc maintenues en vie ont été incubées avec une solution 
d'hexyl-aminolévulinate (HAL), le précurseur de la Protoporphyrine IX. Ces 
muqueuses ont ensuite été irradiées avec des doses lumineuses croissantes en 
lumière bleue et en lumière blanche, et les altérations cellulaires ont été évaluées par 
microscopie électronique à balayage et par un colorant fluorescent, le Sytox green. 
Nous avons également évalué la production d'intermédiaires réactifs de l'oxygène 
par la mesure de la fluorescence intracellulaire de Rhodamine 123 (R123), produit de 
l'oxydation de la Dihydrorhodamine 123 (DHR 123) non fluorescente. Ces valeurs ont 
été corrélées avec celles du photo blanchiment de la PplX. 
Résultats : Le taux de mortalité cellulaire était dépendant de la concentration de 
PplX. Après 3 heures d'incubation, la valeur seuil de dose lumineuse pour la lumière 
bleu était de 0.15 et 0.75 J/cm2 (irradiance 30 et 75 mW/cm2, respectivement) et pour 
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la lumière blanche de 0.55 J/cm2 ( irradiance 30 mW/cm2). Le taux de photo 
blanchiment était inversement proportionnel à l'irradiance. Le système de détection 
des intermédiaires réactifs de l'oxygène DHR123/R123 a démontré une bonne 
corrélation avec les valeurs seuil pour toutes les conditions d'irradiation utilisées. 
Conclusions : Nous avons déterminé les doses lumineuses permettant d'épargner 
50% des cellules urothéliales saines. L'utilisation d'une faible irradiance associée à 
des systèmes permettant de mesurer la production d'intermédiaires réactifs de 
l'oxygène dans les tissus irradiés pourrait améliorer la dosimétrie in vivo et l'efficacité 
de la thérapie photodynamique. 
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Abstract 
Background and Objectives: Photodynamic therapy of superficial bladder cancer may 
cause damages to the normal surrounding bladder wall. Prevention of these is 
important for bladder healing. We studied the influence of photosensitizer 
concentration, irradiation parameters and production of reactive oxygen species 
(ROS) on the photodynamically induced damage in the porcine urothelium in vitro. 
The aim was to determine the threshold conditions for the cell survival. 
Methods: Living porcine bladder mucosae were incubated with solution of hexylester 
of 5-aminolevulinic acid (HAL). The mucosae were irradiated with increasing doses 
and cell alterations were evaluated by scanning electron microscopy and by Sytox 
green fluorescence. The urothelial survival score was correlated with Protoporphyrin 
IX (PplX) photobleaching and intracellular fluorescence of Rhodamine 123 reflecting 
the ROS production. 
Results: The mortality ratio was dependent on PplX concentration. After 3 heurs of 
incubation, the threshold radiant exposures for blue light were 0.15 and 0.75 J/cm2 
(irradiance 30 and 75 mW/cm2 , respectively) and for white light 0.55 J/cm2 (irradiance 
30 mW/cm2). Photobleaching rate increased with decreasing irradiance. lnterestingly, 
the DHR 123/R123 reporter system correlated well with the threshold exposures 
under all conditions used. 
Conclusions: we have determined radiant exposures sparing half of normal urothelial 
cells. We propose that the use of low irradiance combined with systems reporting the 
ROS production in the irradiated tissue could improve the in vivo dosimetry and 
optimize the POT. 
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Introduction 
Photodynamic therapy (POT) is currently approved as an alternative treatment for 
several benign and malignant diseases such as age related macular degeneration, 
cutaneous tumors or upper aero-digestive cancers (1) (2). The therapeutic principle 
relies on a specific light interaction with photosensitized target tissue. A successful 
outcome depends on numerous variables such as physicochemical, pharmacological 
and tissue related properties of the photosensitizer (3). 
ln the case of superficial bladder cancer, the lack of selectivity of the first generation 
photosensitizers (hematoporphyrin derivatives) and some serious adverse effects, 
including skin photosensitization and loss of bladder capacity, slowed down the initial 
enthusiasm for this treatment (4). This was mainly due to the inappropriate 
localization of the photosensitizing agent in the vessels or in the depth of the bladder 
wall. Thus, POT use in urology has remained mainly experimental. 
However, photosensitization based on endogenous photoactive protoporphyrin IX 
(PplX) synthesized upon topical administration of ALA or ALA derivatives such as 
hexyl-aminolevulinate (HAL), clearly renewed the interest of POT development. 
Topically administered, these derivatives have an excellent specificity for epithelia 
such as urothelium with a pronounced affinity for tumor tissue. ALA or HAL based 
fluorescence cystoscopy clearly improves the detection of carcinomas in situ, which 
are precisely the lesions on which POT is assumed to be effective (5) (6) (7). 
An optimal POT necessitates considering specific clinical settings and medical 
indications. While bulky and nodular lesions would suggest the use of red light, 
penetrating better into deeper tissue layers, in the case of urological superficial 
tumors, the use of shorter wavelengths (blue light) might be preferential. For practical 
reasons, the use of white light (containing red component) could be advantageous, 
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also because powerful light sources are readily available in all urological services 
performing fluorescence based photodiagnosis. 
However, as demonstrated in different animal tumor models, some damage to the 
normal urothelium may occur during POT, because normal cells take up the 
precursors as well (8). 
The strong interdependence of irradiance, radiant exposure, photosensitizer 
concentration and possibly also oxygen availability (ROS precursor) represents a 
complex scenario for the definition of an optimal photodynamic dose (9). lndeed, it 
would be extremely difficult to monitor PplX accumulation or ROS production 
explicitly under clinical conditions. Alternatively, assuming that the reactions leading 
to cellular death and to photochemical destruction of the sensitizer are closely 
coupled, an implicit approach is to monitor the decrease of PplX fluorescence (PplX 
photobleaching) during the POT and/or ROS appearance in the urothelium. 
The present work evaluates the cellular photodamage to porcine urothelium with 
respect to the photosensitizer concentration and production of reactive oxygen 
species (ROS). The main objective is to determine irradiation parameters allowing to 
contrai the damage to the normal urothelium. 
Materials and Methods 
Chemicals 
5-aminolevulinic acid hexylester hydrochloride (HAL) was synthesized in our 
laboratory as described previously (10). Solutions of HAL [2 mM] in Tyrode 
bicarbonate buffer were prepared just prior the use and adjusted to pH 5.3. 
Rhodamine 101, Na2HP04, NaH2P04, Glutaraldehyde, Oimethylsulfoxide, Os04, and 
Ethanol were purchased from Fluka (Buchs, Switzerland) and used without further 
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purification. Sytox green and Dihydro-Rhodamine 123 (DHR123) were obtained from 
molecular probes (Eugene, US). Stock solution of DHR 123 in DMSO [1 mM] was 
conserved at -11°C in the dark and diluted for use with Tyrode bicarbonate buffer to 
a final concentration of 10 µmol. 
Preparation of pig bladder mucosae 
Porcine urothelium were prepared and maintained alive according to Marti et al (11): 
Pig bladders were obtained from slaughtered animais and kept in Tyrode solution at 
4 °C until use (1-6 hours post excision). The urothelium was micro dissected from 
underlying tissue and eut into of approximately 7 x 7 mm fragments. These were 
mounted in a thermostabilized (37°C) transparent culture chamber and placed under 
a modified epi-fluorescence microscope. The urothelium divided the chamber into 
epithelial and submucosal compartments. The submucosal compartment was 
continuously perfused by oxygenated Tyrode solution, the apical one was exposed to 
the HAL solution (fig. 1). 
PplX microspectrofluorometry 
During incubation with HAL, the PplX accumulation was followed by 
microspectrofluorometry as described before (11). ln brief, the light of a 1 OOW 
mercury lamp, filtered at 405 ± 5 nm (Eppendorf, Switzerland) was focused (Lens 
Planfluotar x10, NA 0.30, Leitz, Germany) on a 0.003 cm2 area of the urothelial 
surface. The emitted fluorescence passed through a long pass filter (RG610, Schott, 
Germany) and a continuous interference filter (Veril, Leitz, Germany) and was 
recorded by EMI S20 photomultiplier tube. The fluorescence intensity was expressed 
in arbitrary units. ln order to correct possible fluctuations in excitation and emission 
pathways, all measurements of PplX fluorescence intensity were normalized 
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-according to the signal of a reference solution (Rhodamine 101 in ethanol, [1 µM]) at 
635 nm. Tissue autofluorescence, measured in mucosae without preincubation with 
HAL, was shown to be stable and negligible (11). 
Determination of Oxygenating Species 
ln order to measure the intracellular ROS resulting from the illumination, we used the 
Dihydro-Rhodamine 123 (DHR 123)/Rhodamine 123 (R 123). The non-fluorescent 
DHR123 penetrates into the cells and is known to be converted into fluorescent R123 
by a broad range of oxygenating species (12). This system shows minimal overlap of 
its absorption and emission bands with those of PplX (Figure 2A). After the HAL 
preincubation, the accumulation of PplX was determined. The apical compartment of 
the transparent culture chamber was then washed twice with Tyrode solution and 
filled for 15 min with 1 OµM DHR123. The irradiation, i.e., photodynamic "therapy", 
was performed as described below and the fluorescence intensity of R 123 was 
measured at 525 nm using an excitation wavelength of 484 ± 5 nm. Fig. 2B shows 
the kinetics of PplX accumulation until 8 hours of incubation. 
Photodynamic "therapy" 
The urothelium was irradiated at 4 separate spots through the objective of the 
microscope. The power density of the irradiating beam was measured with a 
calibrated power meter (Research Radiometer IL700, International Light, Newbury 
Port, US). At 405 nm (blue light), the irradiances at the epithelial surface of the 
filtered Hg lamp were set to 30 mW/cm2 and 75 mW/cm2, respectively. White light 
illumination was provided by an unfiltered Storz D-Light system (spectral range: 350 
- 680 nm Storz, Tuttlingen, Germany). The white light was delivered by a liquid light 
guide through the ocular of the microscope at 30 mW/cm2 and the urothelial surface 
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illuminated as described above. ln bath cases, the spot size was 0.003 cm2, and care 
was taken that irradiated area was illuminated homogenously. At each irradiation 
spot the time of irradiation, i.e. the radiant exposure was progressively increased and 
the fluorescence intensities of Pp IX at 635 nm and R 123 at 525 nm were measured 
and normalized as previously described. Ten mucosae were used for each condition 
of irradiation. 
Tissue damage evaluation 
The induced tissue damage was evaluated according to a binary score system 
(damage - no damage) based on scanning electron microscopy and confirmed by 
Sytox green, a specific fluorescent probe for cellular death. 
Sytox green fluorescence 
Before fixation for electron microscopy, ten irradiated preparations were incubated 
with Sytox green, which penetrates into dead cells exclusively (13). After 30, 60 and 
90 min, the Sytox green fluorescence was studied (Fig 38) with a combination of 
filters used for Fluorescein isothiocyanate (FITC, excitation at 450-490 nm, emission 
>515 nm). The urothelium was then re-incubated with contrai media for two additional 
hours allowing evaluation of morphological lesions. Without irradiation, no lesions 
cou Id be seen until 7 hours in mucosae whether incubated or not with HAL (11 ). 
Scanning Electron Microscopy 
A "death cell time" interval of 2 hours after irradiation has been defined 
experimentally, according to the Sytox green and electronic microscopy observations 
( see above). 
After the two additional hours, mucosae were fixed overnight in glutaraldehyde (2% in 
phosphate buffered saline) and dehydrated through 70%, 80%, 90% and 100% of 
ethanol. After post-fixation with Os04 (1 % in phosphate buffered saline), the samples 
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were freeze dried with a critical point dryer (CP0030, Balzers, Liechtenstein) coated 
with gold (S 150, Sputter coater, Edwards, Zivy, Basel, Switzerland) and studied by 
SEM (Jed, Tokyo, Japan). Micrographs were recorded on a Kodak Tri-X-Plan (6x7 
cm) roll film. 
The effect of POT was judged on the basis of morphological aspect of the irradiated 
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and non-irradiated areas. Each irradiated area was evaluated according to a binary 
scoring system: score "1" for area showing signs of necrosis (figs.3A, C), score "O" for 
area without any photodynamic damage (Fig 4A). The radiant exposure inducing 
sparring of 50% of cases was defined as the threshold exposure for acceptable 
photodynamic action on normal urothelium. 
Statistics 
Bilateral t-test was used to evaluate the results of PplX bleaching and R123 
fluorescence. ANOVA was used to evaluate the variations due to incubation period 
and radiant exposure. P value of 0.05 is taken as criterion of significance. 
Results 
Accumulation of PplX in the urothelium 
ln presence of HAL, porcine urothelium synthesized the PplX as documented by the 
characteristic emission peaks at 635 nm and 703 nm following excitation at 405 nm 
(fig. 2A). The fluorescence intensity-time profile shows a sigmoid-like character 
(fig.28): following an initial slow phase, PplX fluorescence linearly increases with time 
and then slows down reaching a plateau value after about 8 hours. As described 
below, the amount of intracellular PplX critically determines the sensitivity of 
urothelium to irradiation. 
Cell alterations in the urothelium submitted to HAL mediated POT 
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-Fig. 3 shows scanning electron micrographs of the urothelial surface after 3 hours of 
exposure to HAL followed by focal irradiations and 2 supplementary hours of 
incubation in Tyrode solution. No signs of tissular or cellular abnormalities were 
observed even after 5 hours of incubation with HAL in non-irradiated preparations. 
Also, no damage was observed following a 5 J/cm2 irradiation with white or blue light 
on non-incubated preparations (data not shown). 
ln urothelia incubated with HAL, focal irradiation with blue light (figs. 3A) and white 
light (fig.30) resulted in alterations with distinct morphological characteristics. ln all 
cases, the urothelial damage was strictly limited to the irradiated area and sharply 
demarcated from the non-irradiated surroundings that remained perfectly normal. At 
higher resolution, the damaged areas revealed shrunken, broken and perforated cells 
(fig.3C). Thus, under our conditions, the HAL mediated photo toxicity results in cell 
necrosis. This was consistently confirmed by fluorescence of Sytox green, which was 
present exclusively in the irradiated areas (fig.38). While blue light induced more 
superficial lesions, white light destroyed all cell layers until the basement membrane. 
Although the morphology of the lesions was strongly dependent on the used light 
source and dose, any combination of illumination parameters led to very reproducible 
results. 
Threshold irradiation doses in the normal urothelium 
The outcome of urothelial irradiation has been defined as the fraction of spots 
damaged by the light. The conditions leading to the cell death in 50% of irradiations 
were defined as threshold value to spare normal urothelium. The survival or necrosis 
upon irradiation depends in our conditions on 4 parameters, namely, intracellular 
PplX content, wavelength used, irradiance and time of irradiation (the product of the 
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latter two determines the radiant exposure). The influence of the different factors is 
documented in fig.4 and table 1. 
Fig.4 shows the mortality obtained upon illumination with blue light (75 mW/cm2) and 
with respect to the time of incubation (see fig.2B for corresponding PplX intracellular 
accumulation). After 1 hour of incubation with HAL, no deleterious effects were 
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noticed with a radiant exposure below 0.3 J/cm2 and an exposure as high as 3 J/cm2 
had to be used to induce 100% cell mortality. After 4 hours of incubation with HAL, 
urothelial destruction was observed already at 4 times lower value, about 0.75 J/cm2. 
Most importantly, the use of 0.3 - 0.75 J/cm2 after 2-3 hours of incubation led to the 
desired threshold, i.e., half dead - half intact cells situation. The variations of mortality 
ratio due to the incubation time (PplX accumulation) and radiant exposure are highly 
significant (P<0.02 and P<0.003 respectively, Anova). 
Table 1 shows the results obtained with preparations incubated for 3 hours, which 
represents a clinically acceptable intravesical instillation time. lt shows that the 
highest threshold value was observed with 405 nm and 75 mW/cm2 and the lowest 
for the same wavelength at 30 mW/cm2. For the white light irradiation at 30 mW/cm2, 
an intermediate threshold value was found. For identical irradiance, the threshold 
value for white light irradiation was 3.7 times higher than for blue light irradiation. 
PplX photobleaching and ROS production 
Assuming that the reactions leading to cellular death and to photochemical 
destruction of the sensitizer are closely related, we monitored the decrease of PplX 
fluorescence (PplX photobleaching) and ROS appearance in the urothelium during 
the POT. 
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This was done in urothelium preincubated for 3 hours and irradiated under conditions 
identical to those used to establish the threshold values, i.e., 30 and 75 mW/cm2 for 
blue light and 30 mW/cm2 for the white light. 
Fig.5 shows that, under strictly identical experimental conditions, the kinetics of PplX 
photobleaching and the ROS generation were quasi mirror symme:trical and very 
reproducible. The photobleaching followed a double exponential function and doses 
that led to decrease of initial PplX fluorescence intensity by 1/e value were for the 
blue light 0.37 J/cm2 at 30 mW/ cm2 and 0.68 J/cm2 at 75 mW/cm2. Linder white light, 
the corresponding bleaching radiant exposure was 2.2 J/cm2 at 30 mW/cm2 . The 
increase in fluorescence of R 123 with increasing radiant exposure was also fitted 
according to a sum of two exponential terms. Most interestingly, for the 3 irradiation 
conditions, the total normalized accumulated amount of R123 was the same at the 
corresponding threshold values (table 1 ). Furthermore, for moderate irradiance, i.e. 
30 mW/cm2, the photobleaching data correlated linearly with the R123 intensities 
(fig.5 inserts). 
The threshold values for radiant exposure were correlated with PplX photobleaching 
and R123 accumulation curves for each condition of irradiation (Fig 5). 
Discussion 
Urothelial destruction 
Although tissue photodestruction may result from apoptosis or necrosis (14), the 
mechanisms leading to cell death in the case of HAL mediated PDT presented here 
were mainly due to necrosis. This conclusion, based on scanning electron 
microscopy, was confirmed by the use of Sytox Green known to emit a green 
fluorescence upon penetration in necrotic cells exclusively. We did not use tissue 
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viability test, as it was already done previously (11). We cannot extrapolate from this 
experiment the prevailing cell death mechanism (apoptosis versus necrosis) in 
clinical use. Although our observations demonstrate necrosis, other studies show the 
importance of apoptosis (15) (16). 
An observation which might be of interest in POT strategies in urology is that white 
light irradiation resulted in the destruction and "washout" of the complete urothelial 
layer until the basement membrane. On the contrary, using blue light destroyed only 
superficial layers. 
Sparing of the normal urothelium 
An optimal result of photodynamic therapy would be a complete disappearance of 
tumour areas with a preserved benign surrounding tissue facilitating the healing 
process. Therefore, determination of POT conditions sparing the normal urothelium is 
of major concern. 
For identical irradiances the threshold value for white light irradiation was 3.7 times 
higher than for blue light irradiation. By folding the excitation spectra of the both light 
sources with the absorption spectra of PplX in vitro, one can estimate a relative 
number of absorbed photons for both cases. ln our case, about 2.8 times more 
photons are absorbed when using blue light instead of white light at the same photon 
density. Assuming that the total number of absorbed photons represents a measure 
of produced oxygenating species and that the absorption spectrum of PplX does not 
change considerably in the cell microenvironment, the small difference by a factor 1.3 
(3.7/2.8) could be explained by the formation of photoproducts during POT. 
Fragmentation of the tetrapyrrolic structure has been shown to result in a blue shift of 
the absorption spectra (17). However, when the tetrapyrrolic stem structure remains 
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intact the main photoproducts of PplX formed by POT in vitro have an excitation 
maximum at 450 nm (18). Furthermore, new bands in the far-red region of the 
spectrum will appear. ln general, such photoproducts are also photodynamically 
active and due to their different absorption characteristics will contribute more to the 
phototoxicity under white than under blue irradiation. No specific analysis of the 
different photoproducts in blue or in white light illumination was performed. 
Finally, the threshold values decreased with decreasing irradiance. This observation 
is in agreement with a number of other studies that have reported an enhancement of 
photodynamic damage with decreasing irradiance (19) (20) (21). 
The presented results show that the threshold value for healthy cells depends on a 
compromise between the PplX concentration and the used radiant exposure. For an 
optimized POT, it will be attractive to keep the PplX concentration in normal cells at a 
sub critical level or to use a radiant exposure that enables to preserve the tissue for a 
given concentration. For example, reduction of incubation time from 4 to 2 hours may 
spare about a hait of the urothelium irradiated at 0.75J/cm2. Furthermore, one could 
conclude from these experiments that, for tumor cells that have accumulated PplX 
about 5 times more than normal cells (which in urology is the case for carcinoma in 
situ), one could apply 4 times weaker radiant exposure in order to destroy the tumors 
while keeping the healthy tissue intact. As shown in fig.4, at 405 nm radiant exposure 
of 3 J/cm2 destroyed effectively the PplX loaded urothelium under all conditions 
studied. Using 5-ALA given intravenously, Gronland-Pakkanen et al. (22) have shown 
that superficial bladder damage can be observed in healthy rats urothelium with 
radiant exposures of 20-40 J/cm2 with light at 635 nm, while 80 J/cm2 showed full 
thickness damage. Therefore, they have proposed to use the latter for the destruction 
of GIS. However, as shown by van Staveren et al.(23), POT induced tissue damages 
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can vary according to the route of administration. ln their studies, radiant exposures 
of 1 OO J/cm2 at 635 nm induced irreversible damage to pig bladder walls in vivo, 
when solutions of 5-ALA were applied intravesically at 300mM. Similar conditions 
were used by another group (24) showing that selective damage to chemically 
induced bladder tumors can be achieved without destroying the normal urothelium. 
Photobleaching monitoring and ROS reporter system 
An approach to perform implicit dosimetry consists of monitoring the decrease of 
photosensitizer fluorescence intensity caused by photobleaching. Basically, this 
approach assumes that the same reactions leading to cellular death following POT 
are similarly involved in the photochemical destruction of the photosensitizer. The 
possibility of using photobleaching to monitor dosimetry during POT had been subject 
of numerous studies and an extensive review on this subject has recently been 
reviewed by Wilson et al (25). However, to establish the relationship among the 
photobleaching, the therapeutically active species and the final treatment outcome 
remains a challenge. Only a few studies have focused specifically on the correlation 
of the above-mentioned photosensitizer depletion and the resulting photodynamic 
response of tissue (19, 26-28). ln order to test the hypothesis that photobleaching 
measurements can be used to optimize HAL-mediated POT of superficial bladder 
cancer, we have pre-incubated pig bladder mucosae with HAL during three hours 
and measured the decrease of PplX fluorescence intensity during POT. Under these 
conditions, the PplX fluorescence intensity - time profiles cannot be described by a 
simple exponential function of the radiant exposure and consequently photobleaching 
is not a simple first order process. The traces in fig. 5 represent the weighted non-
linear least square fits of the data using a sum of two exponential terms. ln contrast 
to recent findings of Robinson et al. (19) in hairless mice and of Georgakoudi et al. 
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(29) in vitro, a double exponential decay fitted our photobleaching curves better than 
fitting according to a second order process. Also, Moan et al. (30) described the PplX 
decay during POT in vitro by a sum of two exponential terms, which is in agreement 
with our study. These authors ascribed this characteristic to the relocation of the 
photosensitizer during POT or its chemical modification that contributes to the 
photobleaching process. Furthermore, different photobleaching processes of protein 
bound and unbound photosensitizers have been proposed. 
Nevertheless, our data show that the rate of photobleaching significantly increases 
with decreasing irradiance. Since the oxygen supply is one of the limiting factors in 
POT, this phenomenon could result from a too high initial oxygen consumption 
imposed by a high irradiance. This hypothesis is in agreement with the data and 
calculations of Foster's group (31,32). 
Thus, in vitro, where the initial amount of PplX can be measured, photobleaching 
monitoring at lower irradiance can be used for dosimetry. ln clinical situations, 
however, relative rather than absolute amounts of bleached PplX would be 
measured. ln addition, the fraction of depleted PplX to induce cell death could be 
smaller than the interindividual variations of PplX accumulation. Technically, this 
observation entails a further challenge, since it implies a rather exact assessment of 
small changes against a large background signal having the same optical properties. 
However, the use of other methods for the determination of therapeutic outcomes 
might become important, when the measured amount of photosensitizer cannot be 
directly correlated with the tissular response, as very recently demonstrated by El 
Khatib et al. (33) 
Besides monitoring of photobleaching for dosimetry purposes, other implicit methods, 
such as measuring the photosensitizer triplet state, triplet state lifetimes and use of 
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measurable changes in tissue or environmental fluorescence reporter molecules, 
have rarely been exploited. We have adopted an interesting alternative, i.e., 
monitoring of R123 fluorescence intensity, which reflects the total amount of 
oxygenating species produced during irradiation. ln these experiments, the 
fluorescence intensity of R 123 increased with increasing radiant exposure. Most 
remarkably, for the three irradiation conditions used, the total normalized 
accumulated amount of R 123 was the same at the corresponding threshold values 
(see Table 1). Furthermore, at 30 mW/cm2 , the R123 kinetics correlates linearly with 
the photobleaching data, which again supports the idea of using low irradiances. Due 
to the induction of R123 during POT there might be an additional effect from R123 
induced 102 du ring irradiation with white light. Since, extinction coefficient of R 123 is 
only small at 405 nm, only minimal photodamage can be assumed under blue light 
irradiation. However, R 123 is known to be a relatively weak phototoxin (34) and at the 
concentration of DHR123 used here, the production of ROS resulting by the above 
mentioned reaction should be negligible. 
The introduction of a reporter system such as DHR123/R123 into POT procedure 
would be very useful for the following reasons: a) the total intensity of R 123 can be 
used as direct criterion of the delivered photodynamic dose and, b) the correlation of 
R 123 fluorescence intensity with Pp IX photobleaching helps to optimize the 
irradiance related to the available oxygen concentration. Nevertheless, in this study, 
this ROS reporting system was only used after 3 hours incubation of HAL. Therefore 
we cannot extrapolate what would have been the results according to different 
incubation conditions, which play a role in subcellular PplX localization. 
However, although toxicity and metabolism of R 123 at higher doses has been 
evaluated (35), no human toxicological studies exist on the reporting system 
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DHR123/R123 at the concentration we used in our study. Alternatively, other 
fluorescent reporter systems, known for their sensitivity towards ROS species, such 
as dichlorodihydrofluorescein diacetate and its analogs of dihydrorhodamine 6G, 
might be of potential interest. Although a direct extrapolation to the real in vivo 
situation is not possible for the time being, such extrapolation would imply that the 
R 123 activation would be similar to the cell kill kinetics. This would require similar 
subcellular localization (which might vary for PplX between 1 and 4 hours post 
incubation) and also similar contributions of singlet oxygen and other ROS to the 
R 123 activation and cell kill, respectively. However, the present study shows, for the 
first time, the feasibility to use such ROS reporter systems to monitor a photodynamic 
action during POT by simple fluorescence imaging. 
Conclusions 
For an optimal photodynamic therapy, the determination of conditions sparing the 
normal urothelium facilitating the healing process is of major concern. The in vitro 
preparation of the porcine mucosa preincubated with HAL allowed us to determine 
incubation condition for photodetection in clinics. We also correlated the extent of 
tissue damage with the intracellular PplX concentration, irradiations wavelength and 
irradiance and with the reactive oxygen species produced upon irradiation. 
Under moderate irradiances, photobleaching was found to be a good predictor of 
tissue damage and only a small fraction (10-20%) of PplX had to be destroyed in 
order to induce cell death. ln addition, the DHR123/R123 reporter system was well 
correlated with the threshold exposures under all conditions used. 
We propose that the use of low irradiances combined with systems reporting the 
ROS production in the irradiated tissue could improve the in vivo dosimetry and 
20 
optimize the POT of the superficial bladder carcinoma. Clinical studies are however 
warranted. 
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Legends to tables and figures 
Table 1: Outcome of irradiation of the Pp IX loaded normal porcine urothelium 
Threshold values correspond to irradiation doses resulting in 50% of damaged spots. 
The normalized fluorescence intensity (arbitrary units) of R 123 reflects the total 
reactive oxygen species generated in the illuminated cells. lnterestingly, this value is 
the same whatever the irradiation conditions. Three hours of incubation with HAL. 
Ten mucosae per condition. 
Figure 1: Thermostabilized (37°C) transparent culture chamber placed under a 
modified epi-fluorescence microscope. The urothelium divided the chamber into 
epithelial and submucosal compartments. The submucosal compartment was 
continuously perfused by an oxygenated Tyrode solution, the apical one was 
exposed to the HAL and DHR123 solution. 
Figure 2: Spectral analysis of PplX and Rhodamine 123, and accumulation of PplX 
in the normal urothelium 
A: Spectral analysis of the excitation and emission fluorescence of Pp IX and R 123. 
Note the minimal overlap of R 123 absorption and emission bands with th ose of Pp IX. 
B: Fluorescence intensity (arbitrary units) is proportional to the PplX accumulated in 
the urothelial cells and increases during the incubation with 2 mM HAL. Excitation at 
405 nm, emission measured at 635 nm. 
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Figure 3: Evaluation of the urothelial damage upon irradiation with blue and white 
A: Scanning electron micrograph showing a necrotic lesion of superficial and deeper 
cells. The lesion is strictly confined to the irradiated area (405 nm, irradiance 75 
mW/cm2, dose 5 J/cm2). B: The same preparation as in A was stained prior the 
. 
fixation with Sytox green, which upon penetration into dead cells becomes 
fluorescent. C: Shrunken and perforated cell after irradiation as compared to non 
irradiated urothélium with intact umbrella cells. D: Lesion concerning all the urothelial 
cell layers. The majority of dead cells were washed out but some remaining dead 
cells adhere to an intact basement membrane. Notice again the normal aspect of the 
non-irradiated surrounding urothelium (white light, irradiance 30 mW/cm2 , dose 2 
J/cm2). Incubation with HAL for 3 hours, fixation 2 hours after irradiation 
Figure 4: Influence of irradiation parameters and incubation time on the fate of 
irradiated urothelial cells 
The cell death is defined as the fraction of spots damaged by the light. The 0.5 level 
indicates the threshold conditions. A: After 2 hours of incubation, the threshold value 
is between 0.3 and 0.75 J/cm2 . Ten mucosae per condition, incubation with HAL, 
irradiation with 405 nm light at an irradiance of 75 mW/cm2 . B: Variation of incubation 
with HAL (i.e. PplX concentration) and radiant exposure. Ten mucosae per condition. 
Irradiation with 405 nm light at an irradiance of 75 mW/cm2 . 
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Figure 5: Influence of the light dose on Pp IX bleaching and cell R 123 accumulation 
Pp IX bleaching [squares], cell accumulation of R 123 [circles]. A: blue light, 75 
mW/cm2 . B: blue light, 30 mW/cm2. C: white light, 30 mW/cm2 . The curves represent 
weighted non-linear least square fits of the data using a sum of two exponential 
terms. The bleaching and R123 levels corresponding to threshold doses (see table 1) 
are shown in black symbols. The inserts in B and C indicate that, at low irradiance 
and equivalent doses, there is a good correlation between the relative amount of the 
bleached Pp IX and the cell R 123 fluorescence. Ten mucosae per condition. 
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Table 1: Outcome of irradiation of the Pp IX loaded normal porcine urothelium 
Irradiation Estimated Fraction of Mean Normalized 
Conditions threshold bleached PplX R123 fluorescence 
[J/cm 2] [a.u.] 
' 
Blue Light 0.75 r r0.41±0.10 0.14±0.05 [75mW/cm 2] 
p<0.05 
Blue Light 0.15 p<0.01 l 0.18±0.151 0.14±0.17 
[30mW/cm 2] l 0.11±0.J'' White Light 0.55 0.14±0.05 
[30mW/cm2] 
- - ·- ---··- ----- .. ·-- --
28 
PHOTO-
MULTIPLIER 
.... 
,,.... 
F(t}: accwnulation 
bleaching 
Hg 100W 
1 -<Ill 
405n1n 
excitation 
bean1 
rnetallic box 
HAL Medium 
DHR 
Sytox 
.. 
. 
. 
. 
. 
. 
. 
F(J..): en1isson 
spectrum 
.. 1 
+. rnonochrornator 
. 
. 
. 
. 
white 
light 
dichroic rnirror 
560 rnn 
: etnitted 
~fluorescence : ~----=__,--~­
. 
. 
. 
. 
··-··-··· ····················~ 
~~~~~ 
• 
-··-··-· ·-··-···· .. 
' 
; 
; 
; 
. .... 
Putnps 
Vaucher & al. Fig. 1 
'-' 
-
.... 
-> 400 ('a 
-(J) 
0 
c 
(J) 
0 
r.n 
(J) 200 . ..... 
0 
-> 
..... 
lL 
-
-(J) 
0 
c 
(J) 4-
0 
r.n 
(J) 
' 
-0 
-
::i 2-
0 
400 
' ,. .. .. 
J ' 
. -. 
.. 
1 . -I . . . 
. . 
d \ . . . -. 
. . } l . . . . 
. . 
l ; 
r \~ 
J l 
l 
- PplX excitation 
•••••· PplX emission 
- - - R 123 excitation 
· .... · R123 emission 
.. 
... 
..... 
.... 
.... 
.... 
.... 
.... 
.... 
.... 
.. .. 
.... 
.. .. 
.... 
. .. 
.... 
• • 
.. " 
' . ..  
" & .. .. 
• ...... a• ':. 
.. 
500 600 700 
À [nn1] 
\ 1 1 1 1 1 1 
2 3 4 5 6 7 8 
hours of incubation 
@ 
V au cher & a1. Fig. 2 
._, 
non-
irradiated 
irradiated 
100µm " 
F . .-,. ï/ au cher & al. lg. ~) 
..._, 
® ® 
radiant exposure 
Sam pie 03 J/cm2 0.75 15 3 J/cm2 J/cm2 J/cm2 
1 0 0 0 1 1.0 
2 0 0 1 1 0 
3 0 0 1 1 ro 
4 0 1 1 1 :... ~ 
5 0 1 1 1 
6 0 1 1 1 
... 
·- 0.5 -ro 1.5 ... 
~ 
7 0 1 1 1 
8 0 1 1 1 
9 1 1 1 1 
'lO 1 1 1 1 
0 
O. 75 [J/cm2] E 
/ / 0.3 radiant 0 exposure 
1 2 3 4 
3 hours of incubation hours of incubation 
Vaucher &al. FiQ.4 
(!) 1 . ® u :c: 
4'I 
u 405nm (1) 
4) .a 75mWcm-j,.. 
0 .6 
::i: R123 
q:: .4 
"U 
4) .2 
N 
-CG 
' ' ' ' ' E 0.0 .2 .4 .6 .8 
j,.. Pp IX 0 
:c: O. 
0 5 10 15 20 25 J.cm-2 
1.0 405nm 
_.g 30mWcm-2 
R123 .6 
.4 
.2 
0.0 
0.0 .2 .4 .6 .8 1 .0 
Pp IX 
4 6 8 10 J.cm-2 
4'11.rK>~--=-~~~rrrTTTo-r-:r-...,.....,,.......-r)--~~~~~~ 
u 
:c: 
4) 
0 (!) 
il> 
j,.. 
0 
::i: 
q:: 
"U 
4.'> 
N 
CG 
E j,.. 
0 
:c: 
1.0 ~hitelight 
_.g '30mWcm-2 
R123 .6 
" 
.4 
.2 
0.0 
0.0 .2 .4 .6 .8 1.0 
Pp IX O.~--ir---.-~.----r-=-=~~.-___:,._~~__J 
0 10 20 30 J.cm-2 
irradiance Vaucher & al. Fig. 5 ~ 
